Skip to Main Content

Author Details

Beate Rinner
Medical University of Graz
2000
98
26
Nathan Sheffield (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36710341Targeting epigenetic features in clear cell sarcomas based on patient-derived cell lines.J Transl Med2023
37803350MiR-4649-5p acts as a tumor-suppressive microRNA in triple negative breast cancer by direct interaction with PIP5K1C, thereby potentiating growth-inhibitory effects of the AKT inhibitor capivasertib.Breast Cancer Res2023
38053658Novel combinatorial therapy of oncolytic adenovirus AdV5/3-D24-ICOSL-CD40L with anti PD-1 exhibits enhanced anti-cancer efficacy through promotion of intratumoral T-cell infiltration and modulation of tumour microenvironment in mesothelioma mouse model.Front Oncol2023
36980644MUG CCArly: A Novel Autologous 3D Cholangiocarcinoma Model Presents an Increased Angiogenic Potential.Cancers (Basel)2023
36721821Evaluation of Silibinin Effect on U-CH2 and MCF-7 Cell Lines through xCELLigence System.Adv Pharm Bull2023
35061544Fasting improves therapeutic response in hepatocellular carcinoma through p53-dependent metabolic synergism.Sci Adv2022
35578444The Rise of Three Rs Centres and Platforms in Europe.Altern Lab Anim2022
35628494SK119, a Novel Shikonin Derivative, Leads to Apoptosis in Melanoma Cell Lines and Exhibits Synergistic Effects with Vemurafenib and Cobimetinib.Int J Mol Sci2022
35776213ALYREF, a novel factor involved in breast carcinogenesis, acts through transcriptional and post-transcriptional mechanisms selectively regulating the short NEAT1 isoform.Cell Mol Life Sci2022
36469564MicroRNA mimics can distort physiological microRNA effects on immune checkpoints by triggering an antiviral interferon response.RNA Biol2022
36428530In Model, In Vitro and In Vivo Killing Efficacy of Antitumor Peptide RDP22 on MUG-Mel2, a Patient Derived Cell Line of an Aggressive Melanoma Metastasis.Biomedicines2022
36458800The Current Status and Work of Three Rs Centres and Platforms in Europe.Altern Lab Anim2022
31370667A 3-Dimensional <i>In Vitro</i> Model of Zonally Organized Extracellular Matrix.Cartilage2021
33868466Effects of a combined therapy of bortezomib and ionizing radiation on chondrosarcoma three-dimensional spheroid cultures.Oncol Lett2021
33919827Combination Therapy of Novel Oncolytic Adenovirus with Anti-PD1 Resulted in Enhanced Anti-Cancer Effect in Syngeneic Immunocompetent Melanoma Mouse Model.Pharmaceutics2021
33803437Synthesis and Pharmacological In Vitro Investigations of Novel Shikonin Derivatives with a Special Focus on Cyclopropane Bearing Derivatives.Int J Mol Sci2021
34550531Drug combination screening as a translational approach toward an improved drug therapy for chordoma.Cell Oncol (Dordr)2021
34768746MUG Mel3 Cell Lines Reflect Heterogeneity in Melanoma and Represent a Robust Model for Melanoma in Pregnancy.Int J Mol Sci2021
34445175Effect of L- to D-Amino Acid Substitution on Stability and Activity of Antitumor Peptide RDP215 against Human Melanoma and Glioblastoma.Int J Mol Sci2021
34127734Higher cMET dependence of sacral compared to clival chordoma cells: contributing to a better understanding of cMET in chordoma.Sci Rep2021
34202714Polymer Coated Oncolytic Adenovirus to Selectively Target Hepatocellular Carcinoma Cells.Pharmaceutics2021
34195355Targeted Chemotherapy of Glioblastoma Spheroids with an Iontronic Pump.Adv Mater Technol2021
32559583Periplocin mediates TRAIL-induced apoptosis and cell cycle arrest in human myxofibrosarcoma cells via the ERK/p38/JNK pathway.Phytomedicine2020
31961147β,β-Dimethylacrylshikonin Induces Apoptosis in Melanoma Cell Lines by NOXA Upregulation.J Nat Prod2020
32015475CoCrMo surface modifications affect biocompatibility, adhesion, and inflammation in human osteoblasts.Sci Rep2020
33425870Electrospun PCL/PLA Scaffolds Are More Suitable Carriers of Placental Mesenchymal Stromal Cells Than Collagen/Elastin Scaffolds and Prevent Wound Contraction in a Mouse Model of Wound Healing.Front Bioeng Biotechnol2020
33101071The Influence of an Attachment-Related Stimulus on Oxytocin Reactivity in Poly-Drug Users Undergoing Maintenance Therapy Compared to Healthy Controls.Front Psychiatry2020
32151609Design of human lactoferricin derived antitumor peptides-activity and specificity against malignant melanoma in 2D and 3D model studies.Biochim Biophys Acta Biomembr2020
30557650Extracellular vesicles enhance the targeted delivery of immunogenic oncolytic adenovirus and paclitaxel in immunocompetent mice.J Control Release2019
30709367MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors.Breast Cancer Res2019
30682171Interaction of two antitumor peptides with membrane lipids - Influence of phosphatidylserine and cholesterol on specificity for melanoma cells.PLoS One2019
30419338Pharmacologic IL-6Rα inhibition in cholangiocarcinoma promotes cancer cell growth and survival.Biochim Biophys Acta Mol Basis Dis2019
29520499Towards an in vitro fibrogenesis model of human vocal fold scarring.Eur Arch Otorhinolaryngol2018
30217260Influence of silibinin and β-β-dimethylacrylshikonin on chordoma cells.Phytomedicine2018
29909287Prazosin induced lysosomal tubulation interferes with cytokinesis and the endocytic sorting of the tumour antigen CD98hc.Biochim Biophys Acta Mol Cell Res2018
30308184Silibinin to improve cancer therapeutic, as an apoptotic inducer, autophagy modulator, cell cycle inhibitor, and microRNAs regulator.Life Sci2018
30380804Comparative Gene Expression Analysis in WM164 Melanoma Cells Revealed That <i>β</i>-<i>β</i>-Dimethylacrylshikonin Leads to ROS Generation, Loss of Mitochondrial Membrane Potential, and Autophagy Induction.Molecules2018
30466613Periplocin, the most anti-proliferative constituent of Periploca sepium, specifically kills liposarcoma cells by death receptor mediated apoptosis.Phytomedicine2018
30380765Synthesis of Novel Shikonin Derivatives and Pharmacological Effects of Cyclopropylacetylshikonin on Melanoma Cells.Molecules2018
29725750Characterization of the endolysosomal system in human chordoma cell lines: is there a role of lysosomes in chemoresistance of this rare bone tumor?Histochem Cell Biol2018
28515451HOXA7, HOXA9, and HOXA10 are differentially expressed in clival and sacral chordomas.Sci Rep2017
28258055Somatic <i>TP53</i> mutations characterize preleukemic stem cells in acute myeloid leukemia.Blood2017
28304377Establishment of a novel cellular model for myxofibrosarcoma heterogeneity.Sci Rep2017
28134926DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma.Nat Med2017
28249906NR4A3 Suppresses Lymphomagenesis through Induction of Proapoptotic Genes.Cancer Res2017
28099887Comparative proteomics of paired vocal fold and oral mucosa fibroblasts.J Proteomics2017
29069749<i>In vitro</i> and <i>in vivo</i> cytotoxic activity of human lactoferricin derived antitumor peptide R-DIM-P-LF11-334 on human malignant melanoma.Oncotarget2017
28776571Expanded molecular profiling of myxofibrosarcoma reveals potentially actionable targets.Mod Pathol2017
28522871MUG-Mel2, a novel highly pigmented and well characterized NRAS mutated human melanoma cell line.Sci Rep2017
27072875Establishment of clival chordoma cell line MUG-CC1 and lymphoblastoid cells as a model for potential new treatment strategies.Sci Rep2016
  • 1 - 50 of 98

Recommended Authors

Institute of Biophysics of the Czech Academy of Sciences
Career Start Year 2013
Number of shared co-authors 0
China Pharmaceutical University
Career Start Year 2009
Number of shared co-authors 1
Roswell Park Comprehensive Cancer Center
Career Start Year 2009
Number of shared co-authors 0
National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 1
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 0
Children's Tumor Foundation
Career Start Year 2004
Number of shared co-authors 0
University Hospital Zurich
Career Start Year 2001
Number of shared co-authors 0
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 1
Institut fur Pathologie, Universitatsmedizin Mannheim
Career Start Year 2000
Number of shared co-authors 0
Institute of Pathology, Paracelsus Medical University
Career Start Year 2000
Number of shared co-authors 0
Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)/CIBERONC
Career Start Year 2000
Number of shared co-authors 9
Kaohsiung Medical University
Career Start Year 1998
Number of shared co-authors 0
National Dong Hwa University
Career Start Year 1997
Number of shared co-authors 0
Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin
Career Start Year 1997
Number of shared co-authors 0
Nagasaki University Graduate School of Biomedical Sciences
Career Start Year 1997
Number of shared co-authors 0
Oncode Institute
Career Start Year 1993
Number of shared co-authors 0
Hunter Medical Research Institute, University of Newcastle
Career Start Year 1993
Number of shared co-authors 0
Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine
Career Start Year 1992
Number of shared co-authors 1
Yale School of Medicine
Career Start Year 1992
Number of shared co-authors 2
Instituto do Cancer do Estado de Sao Paulo, Faculdade de Medicina de Sao Paulo
Career Start Year 1989
Number of shared co-authors 0
The Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 1
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1988
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 1
Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia (FPO) - IRCCS
Career Start Year 1988
Number of shared co-authors 2
Hospital Universitario 12 de Octubre
Career Start Year 1988
Number of shared co-authors 1
Netherlands Cancer Institute
Career Start Year 1987
Number of shared co-authors 1
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 1985
Number of shared co-authors 0
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami
Career Start Year 1983
Number of shared co-authors 2
Universite de Paris-Cite
Career Start Year 1979
Number of shared co-authors 0

Collaborators

Medical University of Graz
Co-authored papers 30
Diagnostic and Research Institute of Pathology, Medical University of Graz
Co-authored papers 23
Medical University of Vienna
Co-authored papers 7
Institute of Pathology, Medical University of Innsbruck
Co-authored papers 3
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Cell Therapy Institute, Paracelsus Medical University (PMU)
Co-authored papers 3
Ellen and Ronald Caplan Cancer Center, The Wistar Institute
Co-authored papers 2
Co-authored papers 2
Paracelsus Medical University
Co-authored papers 2
Leiden University Medical Center
Co-authored papers 2
Gottfried Schatz Research Center, Medical University of Graz
Co-authored papers 2
Children's Cancer Research Institute
Co-authored papers 1
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Co-authored papers 1
St. Anna Children's Cancer Research Institute (CCRI)
Co-authored papers 1
PSL Research University, Institut Curie Research Center, INSERM U, Institut Curie
Co-authored papers 1
Flinders University, Flinders Medical Centre
Co-authored papers 1
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Co-authored papers 1
Gottfried Schatz Research Center, Medical University of Graz
Co-authored papers 1
Institut Curie
Co-authored papers 1
St. Anna Children's Cancer Research Institute
Co-authored papers 1
St. Anna Children's Hospital, Medical University of Vienna
Co-authored papers 1
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Co-authored papers 1
Instituto de Salud Carlos III
Co-authored papers 1
Medical University of Graz
Co-authored papers 1
Children's Cancer Research Institute
Co-authored papers 1
Co-authored papers 1
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Co-authored papers 1
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Co-authored papers 1
Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna
Co-authored papers 1
Nancy University Hospital
Co-authored papers 1